Bass, Berry & Sims was named a finalist in 19 categories of the 20th Annual M&A Advisor Awards. The firm was recognized in 18 separate categories related to seven specific deal transactions and was also named a finalist in the Law Firm of the Year category. Each year, these awards recognize the leading dealmakers, firms, and transactions over the past year.
“We are grateful for the recognition again this year by M&A Advisors related to our work in these transactions,” said Kevin Douglas, chair of the Bass, Berry & Sims Corporate & Securities Practice Group. “We are so honored to partner with our clients on such sophisticated work and appreciative that they put their trust in Bass, Berry & Sims for these transactions.”
The firm was recognized for its work in the following seven separate deals:
Sale of Axia Technologies to Bank of America
- Sector Deal of the Year: Financials Deal of the Year
- Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Over $100MM)
- Sector Deal of the Year: Information Technology Deal of the Year (Over $100MM)
- M&A Transaction of the Year: Corporate/Strategic Deal of the Year ($100MM to $1B)
- M&A Transaction of the Year: Private Equity Deal of the Year ($100MM to $250MM)
Acquisition of Healthcare Learning Innovations by Post University and Generation Partners
- Sector Deal of the Year: Professional Services (B2B) Deal of the Year
- M&A Transaction of the Year: Corporate/Strategic Deal of the Year ($50MM to $75MM)
- M&A Transaction of the Year: M&A Deal of the Year ($50MM to $75MM)
Acquisition of Northeast Health Services, LLC by Shore Capital Partners
- Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Under $100MM)
- M&A Transaction of the Year: Private Equity Deal of the Year ($10MM to $25MM)
Acquisition of Eastern Business Forms by Gen Cap America
- Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Under $100MM)
- M&A Transaction of the Year: Private Equity Deal of the Year ($25MM to $50MM)
- M&A Transaction of the Year: M&A Deal of the Year ($25MM to $50MM)
Investment in Regent Surgical Health by TowerBrook Capital Partners L.P. and Ascension Capital
- Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Under $100MM)
- M&A Transaction of the Year: Private Equity Deal of the Year ($75MM to $100MM)
- M&A Transaction of the Year: M&A Deal of the Year ($75MM to $100MM)
Addus HomeCare Corporation Acquires Queen City Hospice, LLC and Affiliate Miracle City Hospice, LLC
- Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Over $100MM)
- M&A Transaction of the Year: Cross-Border Deal of the Year (Over $100MM)
- M&A Transaction of the Year: Private Equity Deal of the Year ($100MM to $250MM)
- M&A Transaction of the Year: M&A Deal of the Year ($100MM to $250MM)
Sale of Velocity Clinical Research to Global Healthcare Opportunities
- Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Over $100MM)
- M&A Transaction of the Year: Private Equity Deal of the Year ($500MM to $1B)
- M&A Transaction of the Year: M&A Deal of the Year ($500MM to $1B)
“Given the backdrop of uncertainty, and the tremendous activity over the past year, these award finalists represent the finest deals and professionals within the M&A industry,” said Roger Aguinaldo, Founder of The M&A Advisor. “This period continues to be ripe with challenges, but also abundant with M&A activity. These professionals were able to navigate through a global pandemic, a distracting presidential election and administration turnover, and a volatile economic turmoil, all the while executing transactions representing several hundred billions of dollars of enterprise value.”
Bass, Berry & Sims has been selected from the nominees in the first stage of evaluation. An independent panel of judges will now select the ultimate award winners in each category to be announced at the 20th Annual M&A Advisor Awards Gala on Wednesday, November 17 at the New York Athletic Club in New York. The Gala will be held in conjunction with the 12th Annual Emerging Leaders Awards Gala. A full list of finalists can be found on The M&A Advisor website.
About Our Corporate & Securities Practice
Public and private companies of all sizes across a variety of industries turn to Bass, Berry & Sims for counsel on a wide range of corporate matters, including mergers, acquisitions and dispositions; capital markets transactions; special purpose acquisition companies (SPACs) and de-SPAC transactions; executive compensation issues; corporate governance; ESG matters; and shareholder activism. We serve as primary corporate and securities counsel to numerous public companies and have counseled on more than 150 deals ranging in size from $20 million to more than $15 billion over the past two years. Click here to learn more about the Corporate & Securities Practice at Bass, Berry & Sims.
Our Private Equity Team has a strong reputation representing funds, lenders, investment banks, and portfolio companies in buy and sell side and growth equity transactions nationally. We have served as lead corporate counsel in hundreds of private equity-backed deals across a variety of industries. Learn more here.